Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Gastric Cancer: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Associated Genes | ACVR2A, AKT, APOPTOSIS, ARID1A, ATP2A3, AURKA, BAD, BAX |
| Therapeutic Agents | Curcumin, Ginger, Nobiletin, Zolbetuximab |
| KG Connections | 473 knowledge graph edges |
| Databases | OMIMOrphanetClinicalTrialsPubMed |
graph TD
Gastric_Cancer["Gastric Cancer"]
Apoptosis["Apoptosis"]
Gastric_Cancer -->|"activates"| Apoptosis
Drug_Resistance["Drug Resistance"]
Gastric_Cancer -->|"therapeutic_target"| Drug_Resistance
Metastasis["Metastasis"]
Gastric_Cancer -->|"regulates"| Metastasis
Immunotherapy["Immunotherapy"]
Gastric_Cancer -->|"therapeutic_target"| Immunotherapy
Epigenetic["Epigenetic"]
Gastric_Cancer -->|"associated_with"| Epigenetic
CANCER(["CANCER"])
CANCER -->|"therapeutic_target"| Gastric_Cancer
Cancer{"Cancer"}
Cancer -->|"therapeutic_target"| Gastric_Cancer
Als{"Als"}
Als -->|"therapeutic_target"| Gastric_Cancer
style Gastric_Cancer fill:#1a3a4a,stroke:#ef5350,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Apoptosis | activates | pathway | 1.00 |
| Drug Resistance | therapeutic_target | pathway | 1.00 |
| Peritoneal Metastasis | associated_with | phenotype | 0.90 |
| Metastasis | regulates | pathway | 0.90 |
| Digestive System Cancers | associated_with | disease | 0.80 |
| Invasion | activates | pathway | 0.80 |
| Immunotherapy | therapeutic_target | pathway | 0.80 |
| Epigenetic | therapeutic_target | pathway | 0.80 |
| Epigenetic | associated_with | pathway | 0.80 |
| Metastasis | activates | pathway | 0.80 |
| Microrna | associated_with | pathway | 0.70 |
| Autophagy | therapeutic_target | pathway | 0.70 |
| Mtor | therapeutic_target | pathway | 0.70 |
| Invasion | expressed_in | pathway | 0.70 |
| Tumor Microenvironment | therapeutic_target | pathway | 0.70 |
| Mapk | therapeutic_target | pathway | 0.70 |
| Ferroptosis | activates | pathway | 0.70 |
| Apoptosis | treats | pathway | 0.70 |
| Mismatch Repair | associated_with | pathway | 0.70 |
| Wnt | therapeutic_target | pathway | 0.70 |
| Angiogenesis | regulates | pathway | 0.70 |
| Microrna | regulates | pathway | 0.70 |
| Pi3K/Akt | regulates | pathway | 0.60 |
| Notch | therapeutic_target | pathway | 0.60 |
| Metastasis | interacts_with | pathway | 0.60 |
| Lysosomal Degradation | activates | pathway | 0.60 |
| Invasion | interacts_with | pathway | 0.60 |
| Cell Cycle | activates | pathway | 0.60 |
| Er Stress | activates | pathway | 0.60 |
| Erk Signaling | inhibits | pathway | 0.60 |
| Egfr Signaling | therapeutic_target | pathway | 0.60 |
| Apoptosis | associated_with | pathway | 0.60 |
| Immune Checkpoint | treats | pathway | 0.60 |
| Mtor | activates | pathway | 0.60 |
| Autophagy | inhibits | pathway | 0.60 |
| Pi3K/Akt | activates | pathway | 0.60 |
| Lipid Metabolism | inhibits | pathway | 0.60 |
| Invasion | implicated_in | pathway | 0.60 |
| Checkpoint Inhibitor | treats | pathway | 0.60 |
| Metastasis | therapeutic_target | pathway | 0.60 |
| Differentiation | therapeutic_target | pathway | 0.60 |
| Pi3K/Akt | associated_with | pathway | 0.60 |
| Dna Methylation | regulates | pathway | 0.60 |
| Histone Modification | regulates | pathway | 0.60 |
| Epigenetic | regulates | pathway | 0.60 |
| Apoptosis | inhibits | pathway | 0.60 |
| Cell Cycle | regulates | pathway | 0.60 |
| Mismatch Repair | activates | pathway | 0.60 |
| Lipid Metabolism | activates | pathway | 0.60 |
| Erk Signaling | causes | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| CANCER | inhibits | gene | 1.00 |
| Cancer | inhibits | disease | 1.00 |
| Cancer | activates | disease | 1.00 |
| CANCER | activates | gene | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Cancer | associated_with | disease | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| APOPTOSIS | activates | gene | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| Tumor | therapeutic_target | disease | 1.00 |
| CANCER | associated_with | gene | 1.00 |
| ERBB2 | associated_with | gene | 0.98 |
| HER2 | associated_with | protein | 0.98 |
| CLDN18 | biomarker_for | protein | 0.95 |
| Zolbetuximab | treats | drug | 0.95 |
| PI3K/AKT/mTOR | associated_with | pathway | 0.95 |
| Chronic Atrophic Gastritis | risk_factor_for | disease | 0.95 |
| Peritoneal Metastasis | associated_with | phenotype | 0.95 |
| CANCER | expressed_in | gene | 0.95 |
| HER2 overexpression | risk_factor_for | phenotype | 0.95 |
| Tumor | associated_with | disease | 0.95 |
| Colorectal Cancer | associated_with | disease | 0.95 |
| MAPK | associated_with | pathway | 0.95 |
| Als | associated_with | disease | 0.95 |
| OVERVIEW | therapeutic_target | gene | 0.95 |
| CANCER | regulates | gene | 0.95 |
| Tumor | activates | disease | 0.95 |
| Tumor | inhibits | disease | 0.95 |
| Claudin 18.2 | biomarker_for | protein | 0.95 |
| Streptococcus anginosus | risk_factor_for | compound | 0.95 |
| Curcumin | treats | compound | 0.95 |
| CLDN18.2 | biomarker_for | protein | 0.95 |
| Nobiletin | treats | compound | 0.93 |
| AURKA | associated_with | gene | 0.92 |
| NF-κB | promotes | pathway | 0.90 |
| gastric intestinal metaplasia | risk_factor_for | phenotype | 0.90 |
| PRMT1 | associated_with | gene | 0.90 |
| ATP2A3 | associated_with | gene | 0.90 |
| PIEZO1 | therapeutic_target | gene | 0.90 |
| Ferroptosis | associated_with | process | 0.88 |
| Caf | contributes_to | cell_type | 0.85 |
| SERCA3 | biomarker_for | protein | 0.85 |
| Hypoxia | associated_with | process | 0.85 |
| PRMT1/BTG2 Axis | involved_in | pathway | 0.85 |
| Cancer | expressed_in | disease | 0.85 |
| Ginger | treats | drug | 0.85 |
| DNA | therapeutic_target | gene | 0.85 |
| EGFR | therapeutic_target | gene | 0.85 |
| MAPK inhibitors | treats | drug | 0.85 |
| MCOLN1 | targets | protein | 0.85 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning Gastric Cancer in their description or question text
No additional research found